The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization (BIO) entered 2024 a little battered, having lost multiple high-profile members and top executives over the past 18 months, not to mention enduring a political battle exemplified by the passage of the Inflation Reduction Act (IRA).
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,